Neuroprotection in diet-induced ketotic rat brain after focal ischemia

Journal of Cerebral Blood Flow and Metabolism

Volumn 28, Issue 12, 2008, Pages 1907-1916

  Puchowicz, Michelle A ^a   Zechel, Jennifer L ^a   Valerio, Jose ^a   Emancipator, Douglas S ^a   Xu, Kui ^a   Pundik, Svetlana ^a   Lamanna, Joseph C ^a   Lust, W David ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BHB; HIF 1; Ketosis; MCAO; Stroke

Indexed keywords

3 HYDROXYBUTYRIC ACID; CARBOHYDRATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN BCL 2; SUCCINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIET; GENE EXPRESSION; KETOACIDOSIS; KETOGENIC DIET; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; STROKE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BRAIN; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KETOGENIC DIET; KETONE BODIES; KETOSIS; MALE; NEUROPROTECTIVE AGENTS; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUCCINIC ACID;

EID: 56649091297     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2008.79     Document Type: Article

References (45)

1. Acker T, Acker H (2004) Cellular oxygen sensing need in CNS function: physiological and pathological implications. J Exp Biol 207(Part 18):3171-88
2. Agani FH, Puchowicz M, Chavez JC, Pichiule P, LaManna J (2002) Role of nitric oxide in the regulation of HIF-1α expression during hypoxia. Am J Physiol Cell Physiol 283:C178-86
3. Chávez JC, Agani F, Pichiule P, LaManna JC (2000) Expression of hypoxic inducible factor 1α in the brain of rats during chronic hypoxia. J Appl Physiol 89:1937-1942
4. Corddry DH, Rapoport SI, London ED (1982) No effect of hyperketonemia on local cerebral glucose utilization in conscious rats. J Neurochem 38:1637-41
5. Dalgard CL, Lu H, Mohyeldin A, Verma A (2004) Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. Biochem J 380(Part 2):419-24
6. Dery MA, Michaud MD, Richard DE (2005) Hypoxia-inducible factor 1: regulation by hypoxic and nonhypoxic activators. Int J Biochem Cell Biol 37:535-40
7. Desrochers S, Quinze K, Dugas H, Dubreuil P, Bomont C, David F, Agarwal KC, Kumar A, Soloviev MV, Powers L, Landau BR, Brunengraber H (1995) R,S-1,3-butanediol acetoacetate esters, potential alternates to lipid emulsions for total parenteral nutrition. J Nutr Biochem 6:111-8
8. Duverger D, MacKenzie E (1988) The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood, glucose, and age. J Cereb Blood Flow Metab 8:449-61
9. Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C (2004) Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann NY Acad Sci 1033:79-91
10. Freeman JM, Vining EPG, Pillas DJ, Pyzik PL, Casey JC, Kelly MT (1998) The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 102(Dec):1358-63
11. Freeman RS, Barone MC (2005) Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders. Curr Drug Targets CNS Neurol Disord 4:85-92
12. Goldberg ND, Passonneau JV, Lowry OH (1966) Effects of changes in brain metabolism on the levels of citric acid cycle intermediates. J Biol Chem 241:3997-4003
13. Gueldry S, Marie C, Rochette L, Bralet J (1990) Beneficial effect of 1,3-butanediol on cerebral energy metabolism and edema following brain embolization in rats. Stroke 21:1458-63
14. Guzman M, Blazquez C (2004) Ketone body synthesis in the brain: possible neuroprotective effects. Prostaglandins Leukot Essent Fatty Acids 70:287-92
15. Hassel B, Sonnewald U (1995) Selective inhibition of the tricarboxylic acid cycle of GABAergic neurons with 3-nitropropionic acid in vivo. J Neurochem 65:1184-91
16. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL (2000) -beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 97:5440-4
17. Kowaltowski AJ, Fiskum G (2005) Redox mechanisms of cytoprotection by Bcl-2. Antioxid Redox Signal 7: 508-514
18. Lust WD, Taylor C, Pundik S, Selman WR, Ratcheson RA (2002) Ischemic cell death: dynamics of delayed secondary energy failure during reperfusion following focal ischemia. Metab Brain Dis 17:113-21
19. Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM (2007) Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 145:256-64
20. Martini WZ, Stanley WC, Huang H, Rosiers CD, Hoppel CL, Brunengraber H (2003) Quantitative assessment of anaplerosis from propionate in pig heart in vivo. Am J Physiol Endocrinol Metab 284:E351-6
21. Mason GF, Petersen KF, de Graaf RA, Shulman GI, Rothman DL (2007) Measurements of the anaplerotic rate in the human cerebral cortex using 13C magnetic resonance spectroscopy and [1-13C] and [2-13C] glucose. J Neurochem 100:73-86
22. Melo TM, Nehlig A, Sonnewald U (2006) Neuronal-glial interactions in rats fed a ketogenic diet. Neurochem Int 48:498-507
23. Mochel F, DeLonlay P, Touati G, Brunengraber H, Kinman RP, Rabier D, Roe CR, Saudubray JM (2005) Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Mol Genet Metab 84:305-12
24. Myllyla R, Tuderman L, Kivirikko KI (1977) Mechanism of the prolyl hydroxylase reaction. 2. Kinetic analysis of the reaction sequence. Eur J Biochem 80:349-57
25. Nehlig A (2004) Brain uptake and metabolism of ketone bodies in animal models. Prostaglandins Leukot Essent Fatty Acids 70:265-75
26. Park SS, Bae I, Lee YJ (2007) Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1 alpha/2alpha is mediated through chelation of iron. J Cell Biochem 103:1989-98
27. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM (2002) Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 52:20-8
28. Pichiule P, LaManna JC (2002) Angiopoietin-2 and rat brain capillary remodeling during adaptation and deadaptation to prolonged mild hypoxia. J Appl Physiol 93:1131-9
29. Prins ML (2008) Cerebral metabolic adaptation and ketone metabolism after brain injury. J Cereb Blood Flow Metab 28:1-16
30. Puchowicz MA, Xu K, Sun X, Ivy A, Emancipator D, LaManna JC (2007) Diet-induced ketosis increases capillary density without altered blood flow in rat brain. Am J Physiol Endocrinol Metab 292:E1607-E1615
31. Reszko AE, Kasumov T, Pierce BA, David F, Hoppel CL, Stanley WC, Des RC, Brunengraber H (2003) Assessing the reversibility of the anaplerotic reactions of the propionyl-CoA pathway in heart and liver. J Biol Chem 278:34959-65
32. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7:77-85
33. Semenza GL (2004) Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19:176-82
34. Sims NR, Heward SL (1994) Delayed treatment with 1,3-butanediol reduces loss of CA1 neurons in the hippocampus of rats following brief forebrain ischemia. Brain Res 662:216-22
35. Slevin M, Kumar P, Gaffney J, Kumar S, Krupinski J (2006) Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin Sci (Lond) 111:171-83
36. Soucek T, Cumming R, Dargusch R, Maher P, Schubert D (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39:43-56
37. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM (2004) The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol 55:576-80
38. Suzuki M, Suzuki M, Kitamura Y, Mori S, Sato K, Dohi S, Sato T, Matsuura A, Hiraide A (2002) Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia. Jpn J Pharmacol 89:36-43
39. Swanson R, Sharpe F (1994) Infarct measurement methodology. J Cereb Blood Flow Metab 14:697-8
40. Tsuda K (2006) Role of hyperglycemia and glutamate receptors in ischemic injury in acute cerebral infarction. Stroke 37:2199
41. Tsujimoto Y (2003) Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 195:158-67
42. Veech RL (2004) The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70:309-19
43. Yang LW, Kasumov T, Yu L, Jobbins KA, David F, Previs SF, Kelleher JK, Brunengraber H (2006) Metabolomic assays of the concentration and mass isotopomer distribution of gluconeogenic and citric acid cycle intermediates. Metabolomics 2:85-94
44. Yudkoff M, Daikhin Y, Melo TM, Nissim I, Sonnewald U, Nissim I (2007) The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. Annu Rev Nutr 27:415-30
45. Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, Humala N, Thiyagarajan M, Wang J, Pasinetti GM (2006) A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 7:29